Literature DB >> 28039179

Immune checkpoint inhibitors-related orchitis.

F Brunet-Possenti1, M A Opsomer2, L Gomez3, I Ouzaid4, V Descamps1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28039179     DOI: 10.1093/annonc/mdw696

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Severe Epididymo-Orchitis and Encephalitis Complicating Anti-PD-1 Therapy.

Authors:  Henry T Quach; Charles J Robbins; Justin M Balko; Charles Y Chiu; Steve Miller; Michael R Wilson; George E Nelson; Douglas B Johnson
Journal:  Oncologist       Date:  2019-04-01

Review 2.  [Andrology in oncological diseases].

Authors:  T Weberschock; S Grunewald; F Ochsendorf
Journal:  Hautarzt       Date:  2018-12       Impact factor: 0.751

Review 3.  Immunotherapy discontinuation - how, and when? Data from melanoma as a paradigm.

Authors:  Caroline Robert; Aurelien Marabelle; Hugo Herrscher; Caroline Caramella; Pascal Rouby; Karim Fizazi; Benjamin Besse
Journal:  Nat Rev Clin Oncol       Date:  2020-07-07       Impact factor: 66.675

4.  Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology.

Authors:  Berna C Özdemir
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751

Review 5.  Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy.

Authors:  Selina K Wong; Caroline A Nebhan; Douglas B Johnson
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.